Aditxt, Inc.
ADTX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001726711
No open-market purchases or sales by Aditxt, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Aditxt, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 23 | 28 | +5 |
| Shares | 2.50M | 2.75M | +246.4K (+9.9%) |
| Value | $1.14M | $392.5K | −$746.0K (−65.5%) |
New holders (9)
Institutions that held Aditxt, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 495,665 | $71.0K | 0.01% |
| Morgan Stanley | 73,741 | $11.0K | 0.00% |
| Jane Street Group, LLC | 68,097 | $10.0K | 0.00% |
| HRT Financial LP | 48,105 | $6.00K | 0.00% |
| UBS Group AG | 30,195 | $4.00K | 0.00% |
| Citigroup Inc | 10,666 | $2.00K | 0.00% |
| Susquehanna International Group, LLP | 11,242 | $2.00K | 0.00% |
| Two Sigma Securities, LLC | 12,170 | $2.00K | 0.00% |
| Ronald Blue Trust, Inc. | 1,080 | $0 | 0.00% |
Sold out (4)
Institutions that held Aditxt, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Sabby Management, LLC | 577,727 | $264.0K |
| BlackRock Inc. | 32,084 | $15.0K |
| Renaissance Technologies LLC | 20,266 | $9.00K |
| Focused Wealth Management, Inc | 1,000 | $0 |